Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of GLP-1 Receptor Enhances Neuronal Base Excision Repair via PI3K-AKT-Induced Expression of Apurinic/Apyrimidinic Endonuclease 1
Jenq‐Lin Yang, Wei‐Yu Chen, Yinping Chen, et al.
Theranostics (2016) Vol. 6, Iss. 12, pp. 2015-2027
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

A Circular RNA Binds To and Activates AKT Phosphorylation and Nuclear Localization Reducing Apoptosis and Enhancing Cardiac Repair
Yan Zeng, William W. Du, Yingya Wu, et al.
Theranostics (2017) Vol. 7, Iss. 16, pp. 3842-3855
Open Access | Times Cited: 351
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Jordan Rowlands, Julian Ik‐Tsen Heng, Philip Newsholme, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 238
Oxidative stress and DNA damage after cerebral ischemia: Potential therapeutic targets to repair the genome and improve stroke recovery
Peiying Li, R. Anne Stetler, Rehana K. Leak, et al.
Neuropharmacology (2017) Vol. 134, pp. 208-217
Open Access | Times Cited: 236
Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1
Jiaming Liu, Fangyan Wang, Suzhi Liu, et al.
Journal of the Neurological Sciences (2017) Vol. 381, pp. 176-181
Closed Access | Times Cited: 178
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 126
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
Niklas Reich, Christian Hölscher
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 116
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access | Times Cited: 2
GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
Sydney S. Wilbon, Mikhail G. Kolonin
Cells (2023) Vol. 13, Iss. 1, pp. 65-65
Open Access | Times Cited: 32
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists
Puja Ghosh, Rosaria Anna Fontanella, Lucia Scisciola, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4872-4884
Open Access | Times Cited: 26
Protective Effects of Notoginsenoside R1 via Regulation of the PI3K-Akt-mTOR/JNK Pathway in Neonatal Cerebral Hypoxic–Ischemic Brain Injury
Liu Tu, Yan Wang, Di Chen, et al.
Neurochemical Research (2018) Vol. 43, Iss. 6, pp. 1210-1226
Open Access | Times Cited: 83
Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties
Alana Gomes de Souza, Adriano José Maia Chaves Filho, João Victor Souza Oliveira, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 429-439
Open Access | Times Cited: 76
Crosstalk between Phosphoinositide 3‐kinase/Akt signaling pathway with DNA damage response and oxidative stress in cancer
Ansar Karimian, Sayed Mostafa Mir, Hadi Parsian, et al.
Journal of Cellular Biochemistry (2018) Vol. 120, Iss. 6, pp. 10248-10272
Closed Access | Times Cited: 69
Liposomes for drug delivery in stroke
Gisele Eva Bruch, Lorena F. Fernandes, Beatriz Lopes Tecedor Bassi, et al.
Brain Research Bulletin (2019) Vol. 152, pp. 246-256
Open Access | Times Cited: 56
Coping with RNA damage with a focus on APE1, a BER enzyme at the crossroad between DNA damage repair and RNA processing/decay
Matilde Clarissa Malfatti, Giulia Antoniali, Marta Codrich, et al.
DNA repair (2021) Vol. 104, pp. 103133-103133
Closed Access | Times Cited: 45
Molecular Mechanism of Vitamin K2 Protection against Amyloid-β-Induced Cytotoxicity
Shu-Hsiang Huang, Sheng-Ting Fang, Yi-Cheng Chen
Biomolecules (2021) Vol. 11, Iss. 3, pp. 423-423
Open Access | Times Cited: 44
Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research
Xiaoyan Yang, Qiang Qiang, Nan Li, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 37
Intake of flavonoids from Astragalus membranaceus ameliorated brain impairment in diabetic mice via modulating brain-gut axis
Xuling Li, Tingting Zhao, Junling Gu, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 37
Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases
Shang‐Der Chen, Yao‐Chung Chuang, Tsu‐Kung Lin, et al.
European Journal of Pharmacology (2022) Vol. 938, pp. 175439-175439
Closed Access | Times Cited: 35
Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases
Wei Peng, Rui Zhou, Zefang Sun, et al.
Aging and Disease (2022) Vol. 13, Iss. 2, pp. 468-468
Open Access | Times Cited: 32
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
Magdalena Złotek, Antonina Kurowska, Mariola Herbet, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3035-3035
Open Access | Times Cited: 17
Unlocking longevity with GLP-1: A key to turn back the clock?
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Maturitas (2024) Vol. 186, pp. 108028-108028
Closed Access | Times Cited: 8
Liraglutide ameliorated peripheral neuropathy in diabetic rats: Involvement of oxidative stress, inflammation and extracellular matrix remodeling
Passant E. Moustafa, Noha F. Abdelkader, Sally A. El Awdan, et al.
Journal of Neurochemistry (2018) Vol. 146, Iss. 2, pp. 173-185
Open Access | Times Cited: 57
Role of primary aging hallmarks in Alzheimer´s disease
Jin Zhao, Jisen Huai
Theranostics (2022) Vol. 13, Iss. 1, pp. 197-230
Open Access | Times Cited: 27
The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype
Toshihiro Noguchi, Hiroyuki Katoh, Satoshi Nomura, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Differential Effects of GLP-1 Receptor Agonists on Cancer Risk in Obesity: A Nationwide Analysis of 1.1 Million Patients
Shauna Levy, Abdallah S. Attia, Rami M. Elshazli, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 78-78
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top